Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women

Fertility and Sterility

Volumn 63, Issue 5, 1995, Pages 1027-1031

  Casson, P R ^a   Faquin, L C ^a   Stentz, F B ^a   Straughn, A B ^a   Andersen, R N ^a   Abraham, G E ^a   Buster, J E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

DHEA replacement; insulin sensitivity; menopause

Indexed keywords

HYDROCORTISONE; INSULIN; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE DEFICIENCY; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BINDING; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0028940840     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)57542-6     Document Type: Article

References (25)

1. L.N. Parker W.D. Odell Decline of adrenal androgen production measured by radioimmunoassay of urinary unconjugated dehydroepiandrosterone J Clin Endocrinol Metab 47 1978 600 602
2. A.G. Schwartz L. Pashko J.M. Whitcomb Inhibition of tumor development by dehydroepiandrosterone and related steroids Toxicol Pathol 14 1986 357 362
3. G.B. Gordon L.M. Shantz P. Talalay Modulation of growth differentiation and carcinogenesis by dehydroepiandrosterone Adv Enzyme Regul 26 1987 355 382
4. T. Suzuki N. Suzuki R.A. Daynes E.G. Engleman Dehydroepiandrosterone enhances IL-2 production and cytotoxic effector function of human T cells Clin Immunol Immunopathol 61 1991 202 211
5. P.R. Casson R.N. Andersen H.G. Herrod F.B. Stentz A.B. Straughn G.E. Abraham Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women Am J Obstet Gynecol 169 1993 1536 1539
6. E.G. MacEwen I.D. Kurzman Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA) J Nutr 121 1991 S51 S55
7. J.E. Nestler C.O. Barlascini J.N. Clore W.G. Blackard Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men J Clin Endocrinol Metab 66 1988 57 61
8. P. Taelman J.M. Kaufman X. Janssens A. Vermeulen Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late postmenopause Maturitas 11 1989 65 73
9. E. Barrett-Connor K.T. Khaw S.S.C. Yen A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease N Engl J Med 315 1986 1519 1524
10. E.D. Schriock C.K. Buffington G.D. Hubert B.R. Kurtz A.E. Kitabchi J.E. Buster Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding J Clin Endocrinol Metab 66 1988 1329 1331
11. E.D. Schriock C.K. Buffington J.R. Givens J.E. Buster Enhanced post-receptor insulin effects in women following DHEA infusion J Soc Gynecol Invest 1 1994 74 78
12. D.C. Cumming R.W. Rebar B.R. Hopper S.S.C. Yen Evidence for an influence of the ovary on circulating DHEA-S levels J Clin Endocrinol Metab 54 1982 1069 1071
13. J.F. Mortola S.S.C. Yenn The effects of oral DHEA on endocrine-metabolic parameters in post menopausal women J Clin Endocrinol Metab 71 1990 696 704
14. J.E. Buster P.R. Casson A.B. Straughn D. Dale E.S. Umstot N. Chiamori Postmenopausal steroid replacement with micronized dehydroepiandrosterone (DHEA): preliminary oral bioavailability and dose proportionality studies Am J Obstet Gynecol 166 1992 1163 1170
15. W. Rosner A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma J Clin Endocrinol Metab 34 1972 983 988
16. R.A. Wild E.S. Umstot G.B. Ranney R.N. Andersen J.R. Givens Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism Am J Obstet Gynecol 146 1983 602 606
17. D. Uebelhart A. Schlemmer J.S. Johansen E. Gineyts C. Christiansen P.D. Delmas Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links J Clin Endocrinol Metab 72 1991 367 373
18. J.H. Wilmore The use of predicted and consistent residual volume in the assessment of body composition by underwater weighing Med Sci Sports Exerc 1 1968 87 90
19. C.K. Buffington T. El-Shiekh A.E. Kitabchi R. Matteri Phytohemagglutinin (PHA) activated human T-lymphocytes: concomitant appearance of insulin binding, degradation and insulin-mediated activation of pyruvate dehydrogenase (PDH) Biochem Biophys Res Commun 134 1986 412 419
20. G.E. Abraham J.E. Buster F.W. Kyle P.C. Corrals R.C. Teller Radioimmunoassay of plasma pregnenolone, 17-hydroxy-pregnenolone and dehydroepiandosterone under various physiological conditions J Clin Endocrinol 37 1973 140 144
21. J. Simon J. Buster Plasma DHEA-S concentration of normal ovulatory women Clin Chem 29 1983 1319 1320
22. G.E. Abraham Ovarian and adrenal contributions to peripheral androgens during the menstrual cycle J Clin Endocrinol Metab 39 1974 340 346
23. C.K. Buffington J.R. Givens A.E. Kitabchi Opposing actions of dehydropiandrosterone and testosterone on insulin sensitivity; in vivo and in vitro studies of hyperandrogenic females Diabetes 40 1991 693 700
24. C.K. Buffington G. Pourmotabbed A.E. Kitabchi Amelioration of insulin resistance in diabetes with dehydroepiandrosterone Am J Med Sci 306 1993 320 324
25. R.N. Bergman D.T. Finegood M. Ader Assessment of insulin sensitivity in vivo Endocr Rev 6 1985 45 86